IMRX
Immuneering
$4.36
+$0.04 (+0.93%)Jul 27, 2026
Key metrics
The numbers that frame IMRX today
- Market cap
- $282.08M
- P/E (TTM)
- -5.2
- EV / FCF
- -4.8
- ROIC
- -86%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $2.90
- 52wk High
- $10.08
Growth
Revenue and earnings trend for IMRX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about IMRX
Is Immuneering a good buy?
No. Immuneering has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks strong, which supports the long-term business case, but that is not enough to offset the weak setup. We think Immuneering is selling at a very high price.
What is the market capitalization of IMRX?
Immuneering's market capitalization is $282.08M.
What is the P/E ratio for IMRX stock?
Immuneering's current P/E ratio is -5.2.
What is the 52-week high for IMRX stock?
The 52-week high for Immuneering is $10.08. The current close of $4.36 is 56.7% below that high.
What is the 52-week low for IMRX stock?
The 52-week low for Immuneering is $2.90. The current close of $4.36 is 50.3% above that low.
Does IMRX stock pay dividends?
Immuneering does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for IMRX?
Immuneering's Debt / Equity ratio is 0.02.